title: Do stem cell-derived islets represent a commercially viable treatment for Type 1 and 2 diabetes?
authors.forename: Adrianne L
authors.initials: AL
authors.lastname: Wong
authors.forename: Concepcion R
authors.initials: CR
authors.lastname: Nierras
mesh_terms: D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000191:economics* / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000191:economics* / Q000628:therapy*; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation / Q000191:economics*; D040541:Marketing; D008954:Models, Biological; D033581:Stem Cell Transplantation / Q000191:economics*; D013234:Stem Cells / Q000166:cytology*; D034421:Sus scrofa; D014183:Transplantation, Heterologous